I have everything needed for a thorough answer. Here it is:
Ischaemic Heart Disease (IHD) - Overview & Pathophysiology
What is IHD?
IHD (also called Coronary Artery Disease / CAD) is a condition in which myocardial oxygen demand exceeds supply, most commonly due to atherosclerotic narrowing of the coronary arteries. It is the leading cause of death worldwide - myocardial infarction alone accounts for roughly one-quarter of all deaths in Western nations.
- Robbins & Kumar Basic Pathology, p. 314
The Central Concept: Supply vs. Demand Mismatch
| Factor | What Happens in IHD |
|---|
| O2 supply | Reduced - atherosclerotic stenosis limits coronary blood flow |
| O2 demand | Normal or increased - heart still needs to pump |
| Net result | Myocardial ischaemia → angina or infarction |
The myocardium is unique in that it extracts nearly all available O2 from coronary blood even at rest, so it cannot compensate by extracting more - the only way to increase supply is to increase coronary flow. Stenosis blocks this ability.
Stage 1 - Endothelial Dysfunction (The Trigger)
The process begins with injury to the vascular endothelium, driven by risk factors such as:
- Hyperlipidaemia (elevated LDL)
- Hypertension
- Cigarette smoking
- Diabetes mellitus
Endothelial cells normally produce nitric oxide (NO), a potent vasodilator that maintains vascular tone and inhibits platelet aggregation. Injury reduces bioavailable NO, causing:
-
Vasoconstriction
-
Pro-inflammatory signalling
-
Increased vascular permeability (allows LDL to enter the intima)
-
Sabiston Textbook of Surgery, p. 2484
Stage 2 - Inflammation & Foam Cell Formation
Once LDL enters the intima, it is oxidised to oxLDL, which:
- Triggers release of adhesion molecules - VCAM-1 and ICAM-1 - on the endothelium
- Recruits monocytes and T lymphocytes from the bloodstream
- Monocytes differentiate into macrophages, which engulf oxLDL via scavenger receptors
- Lipid-laden macrophages become foam cells - the initial visible lesion, called a fatty streak
T cells activated in this environment release TNF-α, IL-1β, IL-6, perpetuating the inflammatory cycle.
Stage 3 - Plaque Formation (Atheroma)
With persistent injury, smooth muscle cells (SMCs) migrate from the media into the intima, driven by cytokines and growth factors. These SMCs then:
- Proliferate
- Synthesise collagen and proteoglycans (extracellular matrix)
- Form a fibrous cap over the accumulated lipid and necrotic debris
The mature atheromatous plaque has two key structural components:
- Fibrous cap - SMCs, macrophages, foam cells, lymphocytes, collagen, elastin
- Necrotic (lipid) core - cell debris, cholesterol crystals, foam cells, calcium
The shoulder areas of the plaque (junction between plaque and normal wall) are the most structurally vulnerable - richest in macrophages and most prone to rupture.
- Robbins & Kumar Basic Pathology, p. 314
Stage 4 - Plaque Instability and Acute Coronary Syndromes
Plaque stability depends on the balance between fibrous cap synthesis and degradation. MMPs (matrix metalloproteinases) secreted by activated macrophages degrade the fibrous cap. Three mechanisms can trigger ACS:
| Mechanism | What Happens | Typical Presentation |
|---|
| Plaque rupture (most common, ~75%) | Fibrous cap tears, exposing lipid core to blood → thrombus | STEMI (complete occlusion) |
| Plaque erosion (~25%) | Superficial endothelial loss, no frank rupture | NSTEMI, more common in women/younger patients |
| Calcified nodule (rare) | Hard calcified deposits breach the cap → sudden occlusion | Variable |
- Sabiston Textbook of Surgery, p. 2485
Risk Factors
| Non-Modifiable | Modifiable |
|---|
| Family history (strongest independent factor) | Hyperlipidaemia |
| Increasing age | Hypertension |
| Male sex | Cigarette smoking |
| Genetic disorders (e.g. familial hypercholesterolaemia) | Diabetes mellitus |
| Obesity, sedentary lifestyle |
| Inflammation (elevated hsCRP) |
Risk factors are multiplicative, not additive. Three simultaneous factors (hyperlipidaemia + hypertension + smoking) increase MI risk 7-fold.
- Robbins & Kumar Basic Pathology, p. 315
Spectrum of Clinical Presentations
Atherosclerosis produces a spectrum of disease depending on how much and how fast the artery is occluded:
Stable Angina → Unstable Angina → NSTEMI → STEMI → Sudden Cardiac Death
(chronic (plaque (partial (complete
fixed stenosis) destabilising) occlusion) occlusion)
- Stable angina: Fixed stenosis (>70% lumen reduction) - chest pain only on exertion, relieved by rest/nitrates
- Unstable angina: Plaque disruption + partial thrombus - pain at rest or minimal exertion, troponin normal
- NSTEMI: Same as UA but with myocardial necrosis (troponin elevated), subendocardial
- STEMI: Complete occlusion, transmural infarction, ST elevation on ECG
- Sudden cardiac death: Lethal arrhythmia (VF) from acute ischaemia or scar-related re-entry
Key Molecular Summary
Risk factors
↓
Endothelial injury → ↓ Nitric Oxide → Vasoconstriction + inflammation
↓
LDL enters intima → oxLDL → Monocyte recruitment → Foam cells → Fatty streak
↓
SMC migration + ECM synthesis → Fibrous cap + Lipid core = Atheroma
↓
Plaque grows → Luminal stenosis → Stable angina (demand ischaemia)
↓
Plaque rupture/erosion → Thrombosis → ACS (supply failure)
- Sabiston Textbook of Surgery; Robbins & Kumar Basic Pathology